Waltham biotech Checkpoint Therapeutics stops cancer study due to Ukraine war


A Waltham biotech is stopping a late-stage clinical trial of a cancer drug because of the ongoing war in Ukraine.

Previous Vyant Bio cancels investor call over 'recent developments' with the potential sale of subsidiary
Next Wake Forest School of Medicine, Atrium Health WF Baptist create digital health platform for stroke patients